What is the purpose of Form 1572?
A form that must be filed by an investigator running a clinical trial to study a new drug or agent. The investigator agrees to follow the U.S. Food and Drug Administration (FDA) Code of Federal Regulations for the clinical trial.
How often does a 1572 need to be updated?
When Must the Form be Updated or a New One Completed? In cases when a new site is added or of replacement of an investigator at an existing site, a 1572 must be submitted to the FDA within a 30-day window of the site’s/investigator’s addition/replacement.
When should the FDA Form 1571 be used?
Form FDA 1571 is used for two purposes: 1) to obtain agreement from the sponsor (or sponsor-investigator) to conduct research according to all appropriate FDA regulations; and 2) to serve as a cover sheet for all submissions to the FDA on behalf of a particular IND.
Who is responsible for making the initial risk determination?
The sponsor-investigator is responsible for making the initial risk determination and presenting it to the IRB. The FDA is available to help sponsor-investigators and IRBs in making the risk determination. The drug manufacturer is not involved in the risk determination for a sponsor-investigator study.
Is 1572 required for IND?
When filing an Initial IND Submission, a completed Form FDA 1572 must be sent from each site. When adding a new investigator (or new site), or replacing an investigator at an existing site. Note: a Form FDA 1572 must be submitted to the FDA within 30 days of the investigator being added.
What is the difference between co investigator and sub investigator?
If a trial is conducted by a team of individuals at a trial site, the investigator is the responsible leader of the team and may be called the principal investigator.” Co-investigator is a term that pre-dates the ICH GCP’s. It has subsequently been replaced by the term sub-investigator.
Do study coordinators need to be on the 1572?
The FAQ states that study coordinators should”usually be listed in Section #6 of the 1572.” This is a significant change from the July 2008 draft FAQ. Many sites do not list studycoordinators on the FDA 1572, which means that most coordinators will need to file financial disclosure information.
Do 1572 expire?
Form Approved: OMB No. 0910-0014 Expiration Date: March 31, 2022 See OMB Statement on Reverse.
Who determines if a device study is significant risk or non significant risk?
Studies of devices that pose a significant risk require both FDA and an Institutional Review Board (IRB) approval prior to initiation of a clinical study. FDA approval is obtained by submitting an IDE application to FDA (§812.20).
When completing an investigator agreement What does the investigator agree to?
In completing Form FDA 1572, Statement of Investigator, the Investigator agrees to: Conduct or supervise the investigation personally.
What is needed for IND filing?
Filing an IND requires completion of 3 sets of forms: 1 detailing the study (FDA Form 1571), 1 providing information about the investigator and study site (FDA Form 1572), and 1 certifying that the study is registered in the national database of clinical trials (FDA Form 3674).
What are the investigator’s legal obligations?
21 CFR 312.60 An investigator is responsible for ensuring that an investigation is conducted according to the signed investigator statement (the FDA’s 1572 form), the investigational plan, and applicable regulations; for protecting the rights, safety, and welfare of subjects under the investigator’s care; and for the …
Who can be a Subinvestigator?
The ICH GCP 1.56 defines sub-investigator as any individual member of the clinical trial designated and supervised by the investigator at a trial site to perform critical trial-related procedures and/or make important trial-related decisions (e.g., associates, residents, research fellows).
Can study coordinators be on the 1572?
Do regulations require a CV to be updated every two years?
CVs should be signed, dated, and updated every 2 years to verify that information is accurate and current. If CVs are filed collectively for the department, include a signed and dated note-to-file indicating the location.